News, infos and good to know WKN: A2QQ2E ISIN: US45256X1037 Kürzel: IBRX Forum: Aktien User: Lirumlarum1

https://www.nbcsandiego.com/news/local/san-diego-union-tribune-sold-to-hedge-fund-alden-global-capital-reductions-coming/3261419/?amp=1

Phase 1 Study Indicates Allogeneic Cytokine-Induced Memory-Like Natural Killer Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer Patients https://ir.immunitybio.com/news-releases/news-release-details/phase-1-study-indicates-allogeneic-cytokine-induced-memory?field_nir_news_date_value[min]=

https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-participate-jefferies-global-healthcare-conference

ImmunityBio: Amidst Difficulty Is Your Opportunity https://seekingalpha.com/article/4605393-immunitybio-amidst-difficulty-is-your-opportunity?mailingid=31523801&messageid=must_reads&serial=31523801.3588896&utm_campaign=Must%2BReads%2BMay%2B18%2C%2B2023&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads

https://investorplace.com/2023/05/the-7-most-undervalued-growth-stocks-for-your-may-buy-list/

https://www.chartmill.com/stock/analyzer/stock/IBRX?view=analyst-ratings&utm_source=stocktwits&utm_medium=ANALYST&utm_content=IBRX&utm_campaign=social_trackinglenove

Check Out What Whales Are Doing With IBRX https://news.finanznachrichten.de/cli/KsdvLSU3DmpBwKtK1OMkmg%253d%253d/https%253a%252f%252fwww.benzinga.com%252fmarkets%252foptions%252f23%252f05%252f32268983%252fcheck-out-what-whales-are-doing-with-ibrx

https://www.urotoday.com/video-lectures/aua-2023/video/3359-assessing-the-effectiveness-of-n-803-for-bcg-unresponsive-bladder-cancer-promising-complete-remission-rates-and-improved-long-term-response-patrick-soon-shiong.html?s=09 Hier der Link zum Interview

ImmunityBio starts Phase llb trial of Lynch syndrome combo therapy https://www.clinicaltrialsarena.com/news/immunitybio-lynch-syndrome/

3 Stocks to Buy That Could Be the Next Biotech Breakthrough https://www.nasdaq.com/articles/3-stocks-to-buy-that-could-be-the-next-biotech-breakthrough

National Multicenter Trial Opens to Study ImmunityBio’s Tri-Ad5 Cancer Vaccines Plus N-803 to Prevent Cancer in People with Lynch Syndrome https://ir.immunitybio.com/news-releases/news-release-details/national-multicenter-trial-opens-study-immunitybios-tri-ad5?field_nir_news_date_value[min]=

2023 ASCO Annual Meeting JUN 2 - JUN 6, 2023 Chicago, IL https://ir.immunitybio.com/events/event-details/2023-asco-annual-meeting

Bankenvorsicht bei Kreditvergabe Yellen nennt Bedingung für Fed-Zinspause https://www.n-tv.de/24055705